Literature DB >> 9800232

Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease.

J D Hooi1, H E Stoffers, A D Kester, P E Rinkens, V Kaiser, J W van Ree, J A Knottnerus.   

Abstract

OBJECTIVES: To describe the risk-factor profile and cardiovascular comorbidity of asymptomatic peripheral arterial occlusive disease (PAOD).
DESIGN: A cross-sectional survey. Asymptomatic PAOD was defined as an ankle-brachial pressure index < 0.95, measured on two consecutive occasions, without intermittent claudication. Logistic regression analyses were performed to investigate independent associations between age, gender, smoking status, hypertension, obesity, diabetes, hypercholesterolaemia, physical activity, a family history of cardiovascular disease, the occurrence of ischaemic heart disease and cerebrovascular disease (CeVD) and asymptomatic PAOD.
SETTING: 18 general practices in the province of Limburg, the Netherlands.
SUBJECTS: A total of 3650 subjects, aged 40-78 years. MAIN
RESULTS: Asymptomatic PAOD was present in 8.6% (n = 314) and symptomatic disease in 3.8% (n = 138) of the participants. Age, smoking status, hypertension, and diabetes were significantly associated with asymptomatic PAOD. The ratio of asymptomatic to symptomatic PAOD was higher among the younger age groups. Male gender, hypertension and smoking status were stronger associated with symptomatic PAOD compared with asymptomatic PAOD. Asymptomatic subjects had more IHD and CeVD comorbidity compared with the healthy population.
CONCLUSION: Our findings suggest that the risk-factor profile and cardiovascular comorbidity of asymptomatic subjects is comparable to claudicants. Preventive efforts could be made to diminish the influence of especially smoking, diabetes and hypertension in asymptomatic subjects.

Entities:  

Mesh:

Year:  1998        PMID: 9800232     DOI: 10.1080/028134398750003142

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  19 in total

Review 1.  Ginkgo biloba for intermittent claudication.

Authors:  Saskia P A Nicolaï; Lotte M Kruidenier; Bianca L W Bendermacher; Martin H Prins; Rutger A Stokmans; Pieter P H L Broos; Joep A W Teijink
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

2.  [Value of color-coded duplex sonography in preoperative visualization of lower leg arteries for microsurgical fibula transfer].

Authors:  D Gülicher; A Wersebe; S Reinert
Journal:  Mund Kiefer Gesichtschir       Date:  2005-05

3.  Costs and medical care consequences associated with the diagnosis of peripheral arterial disease.

Authors:  Kristen Migliaccio-Walle; J Jaime Caro; Khajak J Ishak; Judith A O'Brien
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study.

Authors:  Claudio Cimminiello; Claudio Borghi; Serge Kownator; Jean Claude Wautrecht; Christos P Carvounis; Stefanus E Kranendonk; Beat Kindler; Mario Mangrella
Journal:  BMC Cardiovasc Disord       Date:  2010-08-05       Impact factor: 2.298

Review 5.  The role of nutrition and body composition in peripheral arterial disease.

Authors:  Diana P Brostow; Alan T Hirsch; Tracie C Collins; Mindy S Kurzer
Journal:  Nat Rev Cardiol       Date:  2012-08-28       Impact factor: 32.419

Review 6.  Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology.

Authors:  Joshua W Knowles; Themistocles L Assimes; Jun Li; Thomas Quertermous; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-26       Impact factor: 8.311

7.  Differences in presentation of symptoms between women and men with intermittent claudication.

Authors:  Birgitta Sigvant; Fredrik Lundin; Bo Nilsson; David Bergqvist; Eric Wahlberg
Journal:  BMC Cardiovasc Disord       Date:  2011-06-30       Impact factor: 2.298

8.  The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database.

Authors:  Jaime Caro; Kristen Migliaccio-Walle; Khajak J Ishak; Irina Proskorovsky
Journal:  BMC Cardiovasc Disord       Date:  2005-06-22       Impact factor: 2.298

9.  The ClaudicatioNet concept: design of a national integrated care network providing active and healthy aging for patients with intermittent claudication.

Authors:  Gert-Jan Lauret; Harm J H Gijsbers; Erik J M Hendriks; Marie-Louise Bartelink; Rob A de Bie; Joep A W Teijink
Journal:  Vasc Health Risk Manag       Date:  2012-08-24

10.  Peripheral Arterial Disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality.

Authors:  María Teresa Alzamora; José Miguel Baena-Díez; Marta Sorribes; Rosa Forés; Pere Toran; Marisa Vicheto; Guillem Pera; María Dolores Reina; Carlos Albaladejo; Judith Llussà; Magda Bundó; Amparo Sancho; Antonio Heras; Joan Rubiés; Juan Francisco Arenillas
Journal:  BMC Public Health       Date:  2007-12-11       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.